Cru Silva was diagnosed with a type of eye cancer when he was 18 months old. After nearly a year of treatments, he's healthy and back home in Hawaii.
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
In this excerpt originally in Months to Years, Michelle Mindlin reflects on how she found courage as she faced cancer repeatedly.
Proteins that guide transcription factors from the nuclear membrane to the DNA cause drug-resistant skin cancers and are new targets for drug development.
A decades-long scientific collaboration points the way to therapies for "chemo brain," the cognitive impairment that follows cancer treatment.
Stanford and SLAC researchers are developing new technology to dramatically reduce the duration of radiation therapy and its treatment side effects.
The leading cause of death in the U.S. is shifting from heart disease to cancer at varying paces across the country, according to Stanford research.
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
A Stanford team has developed an algorithm that uses data about tumors to identify new classifications that can provide information about patient outcomes
A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.
In a new study, a team of researchers has examined the relationship between protein binding to DNA and the development of cancer.
A new generation of brain cancer patients are working to improve care and connect and support patients using social media and advocacy.
Stanford researchers have learned that cancer cells can batter their way into new territory, rather than relying on dissolving chemicals.
Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.